The Indirect Psychological Costs of Cognitive Enhancement

American Journal of Bioethics

Volumn 13, Issue 7, 2013, Pages 45-47

  Faulmüller, Nadira ^a   Maslen, Hannah ^a   de Sio, Filippo Santoni ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880960238     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265161.2013.794880     Document Type: Article

References (10)

1. Bastian, B. and Haslam, N. 2011. Experiencing dehumanization: Cognitive and emotional effects of everyday dehumanization. Basic and Applied Social Psychology, 33: 295-303. doi: 10.1080/01973533.2011.614132
2. Bell, S., Partridge, B., Lucke, J. and Hall, W. 2013. Australian university students' attitudes towards the acceptability and regulation of pharmaceuticals to improve academic performance. Neuroethics, 6: 197-205. doi: 10.1007/s12152-012-9153-9
3. Dubljević, V. 2013. Prohibition or coffee shops: Regulation of amphetamine and methylphenidate for enhancement use by healthy adults. American Journal of Bioethics, 13 (7): 23-33.
4. Forlini, C. and Racine, E. 2010. Stakeholder perspectives and reactions to "academic" cognitive enhancement: Unsuspected meaning of ambivalence and analogies. Public Understanding of Science, 21: 606-625. doi: 10.1177/0963662510385062
5. Gilbert, D. T and Jones, E. E. 1986. Perceiver-induced constraint: Interpretations of self-generated reality. Journal of Personality and Social Psychology, 50: 269-280. doi: 10.1037/0022-3514.50.2.269
6. Husain, M. and Mehta, M. A. 2011. Cognitive enhancement by drugs in health and disease. Trends in Cognitive Sciences, 15: 28-36. doi: 10.1016/j.tics.2010.11.002
7. Ilieva, I., Boland, J. and Farah, M. J. 2013. Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy people. Neuropharmacology, 64: 496-505. doi: 10.1016/ j.neuropharm.2012.07.021
8. Nutt, D., King, L. A., Saulsbury, W. and Blakemore, C. 2007. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet, 369 (2007): 1047-1053. doi: 10.1016/S0140-6736(07)60464-4
9. Weinberg, B. A. and Bealer, B. K. 2001. The world of caffeine: The science and culture of the world's most popular drug, New York, NY: Routledge.
10. Williams, K. D. and Nida, S. A. 2011. Ostracism: Consequences and coping. Current Directions in Psychological Science, 20: 71-75. doi: 10.1177/0963721411402480